After a three-day investigation in September, CMS found problems in the pharmacy that included missing medication labels, unsystematic labeling of medication and incompetence among the staff.
The report details several instances of patients’ safety being jeopardized, including one in which a patient went into anaphylactic shock after an incorrectly filled medication was administered. A nurse told CMS regulators that the medication had been pulled from the automated dispensing system under an erroneous name several times. Another time, the pharmacy delivered morphine at a dosage five times greater than the physician prescribed.
Several staff members said they feared retaliation if they reported concerns to the hospital administration. Four physicians told CMS that they told hospital administrators that the pharmacists lacked experience and medication errors were on the rise.
The CMS survey follows reports of 45 medication errors that were reported at the hospital in July and August.
Dillingham-based Bristol Bay Area Health Corp., which owns the hospital, said it has submitted a plan of correction to CMS. Under the plan, the provider will train new staff and update procedures.
More articles on healthcare finance:
California dialysis initiative prompts hundreds of millions in spending
Ballot measures in 2 California cities take aim at healthcare costs
Mississippi hospital ends ER fee for nonemergencies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.